z-logo
Premium
Systematic epitope analysis of the p26 EIAV core protein
Author(s) -
Soutullo Adriana,
Santi María N.,
Perin Juan C.,
Beltramini Leila M.,
Borel Ileana Malan,
Frank Ronald,
Tonarelli Georgina G.
Publication year - 2007
Publication title -
journal of molecular recognition
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.401
H-Index - 79
eISSN - 1099-1352
pISSN - 0952-3499
DOI - 10.1002/jmr.825
Subject(s) - epitope , equine infectious anemia , polyclonal antibodies , virology , antibody , epitope mapping , peptide , antigen , linear epitope , biology , peptide sequence , conformational epitope , chemistry , virus , microbiology and biotechnology , biochemistry , immunology , gene
The major core protein of equine infectious anemia virus (EIAV), p26, is one of the primary immunogenic structural proteins during a persistent infection of horses and is highly conserved among antigenically variants of viral isolates. In order to investigate its immune profile in more detail for a better diagnostic, an epitope mapping was carried out by means of two libraries of overlapping peptide fragments prepared by simultaneous and parallel SPPS on derivatized cellulose membranes (SPOT synthesis). Polyclonal equine sera from infected horses were used for the biological assay. Particularly two promising continuous epitopes (NAMRHL and MYACRD) were localized on the C‐terminal extreme of p26, region 194–222. A cyclic synthetic fragment of 29 amino acid residues containing the identified epitopes was designed and studied. A significant conformational change towards a helical structure was observed when the peptide was cyclized by a bridge between Cys198 and Cys218. This observation correlated with an improvement of its ability to be recognized by specific antibodies in an EIA (Enzyme‐linked Immunosorbent assay). These results suggest that the conformationally restricted synthetic antigen adequately mimics the native structure of this region of p26 core protein. Copyright © 2007 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here